Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ignoring Avago Technologies Ltd (AVGO) Isn’t a Good Idea, Even Though it’s Witnessing Short-term Weakness: Apple Inc. (AAPL), Research In Motion Ltd (BBRY)

Page 1 of 2

When Singapore-based semiconductor company Avago Technologies Ltd (NASDAQ:AVGO) released its first-quarter report last week, it didn’t spring much of a surprise. The company met expectations on revenue and beat on earnings, but this is the least it should have done, since estimates were already quite low after Avago had issued a gloomy outlook the quarter before.

However, Avago Technologies Ltd (NASDAQ:AVGO) guided below Street expectations yet again for next quarter. While analysts were expecting a sequential increase in revenue to $583 million, Avago thought otherwise. It expects its top line to shrink 2% to 5% in the second quarter, as a product ramp up at its Korean customer won’t be enough to offset the annual product transition at its North American customer.

Avago Technologies LtdA quarter’s pain

As you would have guessed, these customers are Apple Inc. (NASDAQ:AAPL) and Samsung, to whom Avago supplies wireless chips that prevent interference between various kinds of radio signals. According to CEO Hock Tan, product transition at Apple has arrived a quarter earlier this time, and this knocked out some wind out of Avago’s sails.

Apple Inc. (NASDAQ:AAPL), through Foxconn, accounted for 17% of Avago Technologies Ltd (NASDAQ:AVGO)’s revenue last year. Thus, the weakness of the latest iPhone was bound to have a negative effect of Avago this quarter. According to Jefferies analyst Peter Misek, sales of iPhone 5 have slowed down earlier than expected, leading Apple to issue further order cuts.

However, as Misek pointed out, preparation for the next iPhone is expected to start this month. As the iPhone transition appeared a quarter earlier, one can expect Apple Inc. (NASDAQ:AAPL) to start preparing its next flagship earlier as well, and this should help Avago in the next quarter when orders start flowing in.

The presence of Samsung as a customer was the saving grace for Avago, as it acted as a hedge against Apple’s weakness. Avago had supplied chips to Samsung for the Galaxy S III. With the next iteration of the Korean giant’s flagship on the horizon, Avago Technologies Ltd (NASDAQ:AVGO) saw better orders from Samsung, and this salvaged its outlook to some extent.

A bite of the berry

Another shot in the arm for Avago could be its presence inside Research In Motion Ltd (NASDAQ:BBRY)’s messiah, the Z10. Even though the flagship has yet to be launched in the U.S., it is off to a good start in other countries. For instance, reports suggest that the Z10 appears to be doing well on its home turf in Canada, as well as in the U.K., by taking away share from other platforms.

Moreover, the smartphone has started off well in an important market such as India despite steep pricing, which establishes the fact that consumer loyalty could help Research In Motion Ltd (NASDAQ:BBRY) regain some of its lost market share. This, in turn, should prove beneficial for Avago Technologies Ltd (NASDAQ:AVGO).

Apart from these bigwigs, Avago is also finding traction at other phone makers in regions such as Taiwan, Korea, and China. Growth of 4G LTE devices and increasing FBAR content are expected to help Avago going forward. The company invested $300 million for quadrupling its FBAR capacity, as it expects increasing sales of LTE devices to result in higher demand for its chips.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!